TickerFactsScreenerDevelopers

PharmaCyte Biotech, Inc. (PMCB) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$225.2K2012: -$259.3K2013: -$390.4K2017: -$3.34M2018: -$5.08M2019: -$2.88M2020: -$2.34M2021: -$3.33M2022: -$4.12M2023: -$3.79M2024: -$2.15M2025: -$2.98M-$2.98M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$2.98M-38.4%
2024-$2.15M+43.3%
2023-$3.79M+7.9%
2022-$4.12M-23.6%
2021-$3.33M-42.4%
2020-$2.34M+18.7%
2019-$2.88M+43.3%
2018-$5.08M-52.1%
2017-$3.34M—
2013-$390.4K-50.6%
2012-$259.3K-15.1%
2011-$225.2K—